X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
platinum-based chemotherapy (1652) 1652
humans (1355) 1355
oncology (1240) 1240
index medicus (1050) 1050
female (885) 885
chemotherapy (664) 664
middle aged (655) 655
cancer (645) 645
aged (588) 588
male (499) 499
adult (494) 494
lung neoplasms - drug therapy (464) 464
antineoplastic combined chemotherapy protocols - therapeutic use (453) 453
carcinoma, non-small-cell lung - drug therapy (425) 425
cisplatin (394) 394
treatment outcome (366) 366
prognosis (343) 343
antineoplastic agents - therapeutic use (332) 332
survival (313) 313
care and treatment (291) 291
neoplasm staging (286) 286
phase-iii trial (277) 277
lung cancer (264) 264
ovarian cancer (263) 263
aged, 80 and over (241) 241
lung neoplasms - pathology (233) 233
disease-free survival (229) 229
docetaxel (226) 226
carcinoma (221) 221
lung cancer, non-small cell (219) 219
non-small cell lung cancer (208) 208
paclitaxel (208) 208
carcinoma, non-small-cell lung - pathology (207) 207
research (207) 207
hematology, oncology and palliative medicine (206) 206
cell lung-cancer (205) 205
ovarian neoplasms - drug therapy (199) 199
retrospective studies (198) 198
survival analysis (185) 185
cisplatin - administration & dosage (182) 182
obstetrics & gynecology (180) 180
lung neoplasms - genetics (176) 176
lung neoplasms - mortality (170) 170
analysis (166) 166
respiratory system (166) 166
pharmacology & pharmacy (163) 163
survival rate (158) 158
carboplatin (155) 155
randomized-trial (155) 155
carcinoma, non-small-cell lung - genetics (151) 151
carcinoma, non-small-cell lung - mortality (150) 150
supportive care (147) 147
antineoplastic combined chemotherapy protocols - adverse effects (145) 145
quality-of-life (142) 142
genetic aspects (136) 136
health aspects (134) 134
ovarian neoplasms - pathology (134) 134
phase-ii trial (133) 133
tumors (129) 129
drug therapy (128) 128
gemcitabine (126) 126
growth-factor receptor (125) 125
open-label (125) 125
cancer therapies (124) 124
dna-binding proteins - genetics (123) 123
gynecologic-oncology-group (123) 123
metastasis (123) 123
ercc1 (120) 120
carcinoma, squamous cell - drug therapy (119) 119
therapy (119) 119
trial (116) 116
expression (115) 115
deoxycytidine - analogs & derivatives (114) 114
nsclc (111) 111
patient outcomes (111) 111
cetuximab (110) 110
carboplatin - administration & dosage (109) 109
combined modality therapy (109) 109
quality of life (109) 109
radiotherapy (108) 108
neoplasm recurrence, local - drug therapy (107) 107
paclitaxel - administration & dosage (107) 107
1st-line treatment (106) 106
medicine & public health (106) 106
taxoids - administration & dosage (105) 105
combination chemotherapy (104) 104
drug resistance, neoplasm (102) 102
squamous-cell carcinoma (101) 101
endonucleases - genetics (100) 100
polymorphism, single nucleotide (100) 100
patients (99) 99
cisplatin - therapeutic use (98) 98
dna-repair (98) 98
gefitinib (98) 98
clinical trials (97) 97
surgery (97) 97
head and neck neoplasms - drug therapy (96) 96
deoxycytidine - administration & dosage (95) 95
antineoplastic agents - adverse effects (94) 94
breast-cancer (93) 93
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1801) 1801
French (19) 19
German (9) 9
Polish (4) 4
Spanish (3) 3
Italian (2) 2
Japanese (2) 2
Korean (2) 2
Russian (2) 2
Hungarian (1) 1
Portuguese (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2006, Volume 355, Issue 10, pp. 983 - 991
Journal Article
Journal Article
Journal Article
Oral Oncology, ISSN 1368-8375, 2012, Volume 48, Issue 11, pp. 1146 - 1151
Journal Article
Journal Article
Investigational New Drugs, ISSN 0167-6997, 2/2012, Volume 30, Issue 1, pp. 200 - 211
Altered metabolism of cancer first highlighted by Otto Warburg has a long history. Although ignored for a considerable amount of time, it is now receiving... 
Oncology | Pyruvate dehydrogenase | Metabolic therapy | Medicine & Public Health | Pharmacology/Toxicology | ATP citrate lyase | APOPTOSIS | DICHLOROACETATE DCA | PANCREATIC-CANCER | METHOTREXATE | PHASE-II | CELL-GROWTH | NECK-CANCER | DNA ADDUCTS | IN-VITRO | ONCOLOGY | PLATINUM-BASED CHEMOTHERAPY | PHARMACOLOGY & PHARMACY | Carcinoma, Pancreatic Ductal - secondary | Thioctic Acid - administration & dosage | Pancreatic Neoplasms - metabolism | Humans | Carcinoma, Pancreatic Ductal - metabolism | Tomography, X-Ray Computed | Cisplatin - administration & dosage | Pancreatic Neoplasms - drug therapy | Citrates - administration & dosage | Time Factors | Urinary Bladder Neoplasms - pathology | Aged, 80 and over | Female | Urinary Bladder Neoplasms - metabolism | Deoxycytidine - administration & dosage | Mice, Inbred C57BL | Pancreatic Neoplasms - pathology | Treatment Outcome | Urinary Bladder Neoplasms - drug therapy | Carcinoma, Lewis Lung - metabolism | Mice, Inbred C3H | Carcinoma, Lewis Lung - drug therapy | Carcinoma, Pancreatic Ductal - drug therapy | Animals | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Carcinoma, Lewis Lung - pathology | Cell Line, Tumor | Methotrexate - administration & dosage | Mice | Deoxycytidine - analogs & derivatives | Energy Metabolism - drug effects | Cell metabolism | Physiological aspects | Development and progression | Genetic aspects | Drug therapy | Tumors | Studies | Chemotherapy | Pharmacology | Cancer therapies
Journal Article